Home | About | RSS Feed | Contact and Publicity Guidelines | Comment Policy the Law, the Universe, and Everything 

advertise-here4


Slip Opinions


Whatever happened to Henry Simons? (fp)

Wow -- that's some very scary poll results (kw)

The scarlet ankle bracelet. (fp)

Every good article should have one idea. (fp)

Family values in market turnover culture. (fp)

Banks really create value: probably $58 billion in overdraft fees & credit card penalties in 2009. (fp)

A Citizens United dream: Exxon could have deployed 10% of its 2008 profits to outspend every presidential and senatorial candidate that year. (fp)

Eternal Earth-Bound Pets promises to adopt your pet if you are raptured. (fp)

Habermas doesn't tweet, but does interview well. (fp)

Lessig on Google, copyright, orphans, and the future of access to information. (kw)

Our Podcast

Subscribe to Law Talk

law-rev-contents2.jpg


  • Posts by Author

  • Categories

  • Archives


  • Recent Comments

    • Kristina on Spring 2010: Is the Window Open?

    • PrometheeFeu on The Advantages and Disadvantages of Rewards

    • PoNyman on Very scary poll results

    • Civ Pro King on Privacy Rights in Death Photos: Catsuouras Case Decided

    • ParatrooperJJ on Privacy Rights in Death Photos: Catsuouras Case Decided

    • Lotta on The Take Away About Take Home Exams

    • Alan on Constitutional Rorschach Test (or Zen Koan)

    • Colin Crowe on The Take Away About Take Home Exams

    • Glomarization on Links and short thoughts on Amazonfail

    • Vinca on Book Review: Divergent Opinions: Why Community Matters — A Review of Sunstein’s Going to Extremes

    • A.J. Sutter on My Letter to the Economist on Climate Change

    • Keri Brooks on Spring 2010: Is the Window Open?

    • Illinois on Spring 2010: Is the Window Open?

    • Ken Rhodes on Constitutional Rorschach Test (or Zen Koan)

    • Ken Rhodes on My Letter to the Economist on Climate Change

  •  

    Site Meter

The Market for Medicalization: Enhancing Evolution?

posted by Frank Pasquale

shy.jpgMany recent books are questioning the expansive trend toward “medicalizing” emotional responses that were once considered acceptable. I greatly enjoyed Christopher Lane’s Shyness: How a Normal Behavior Became a Sickness, and I’ve just started in on Peter Conrad’s The Medicalization of Society: On the Transformation of Human Conditions Into Treatable Disorders. Metapsychology has given a positive review to Horwitz and Wakefield’s The Loss of Sadness: How Psychiatry Transformed Normal Sorrrow into Depressive Disorder. The authors argue that “instances of what Freud called ‘ordinary human misery’ should not be confused with real mental disorder”–but there are many pressures toward treating them as such.

As the realm of “mental optimization” expands, I predict more employers will request (or demand) employees take certain drugs. For example, someone grieved by a loss might become much more productive if they can nip misery in the bud with the right intervention. Will such pill-taking ever become a bona fide occupational qualification? Are there cases where it might make sense?


I think it is helpful to think about two “ideal types” here. First, imagine some pill that makes pilots particularly acute during their flights, or gives them better vision, with no side effects. Second, imagine a personality “brightener” that a company believes makes its sales force far more fun and personable. Is one intervention less objectionable than the other?

I think the first is far more understandable, because flying has some objective standards (most notably, don’t crash). By contrast, the sales force is engaged in what is essentially a positional competition for more revenue–there’s no way to define “good performance” that is not relative to how well other employees are doing. (For an example, consider Jack Welch’s famous policy of knocking out the bottom 10% of employees each year–or the struggle for a partnership at a law firm.) Moreover, the first intervention is unlikely to affect the personality of the pilots, while the latter may go to the heart of personality.

A few parting thoughts. First, thanks to Patrick at the Medical Humanities Blog for pointing out Christian Perring’s superb article on clarifying the concept of mental illness. I have worried that greater pressure to perform will lead to an endless expansion of this category.

Second, the pressures to take chemical enhancements should lead us to question any sanguine characterization of the ethics of enhancement as a purely personal and individual matter. In his Enhancing Evolution, John Harris argues that “citizens should be free to make their own choices in the light of their own values, whether or not these choices and values are acceptable to the majority.” As Jonathan Franzen suggested in The Corrections, a positional rat race may be driving personality optimization far more concretely than “individual values.” Harris briefly mentions positional competitions in his book before throwing up his hands at solving them. Thankfully theorists like Jonathan Wolff and Avner de-Shalit are taking the issue more seriously. Where Harris sees the “enhancement” of evolution, many others may more justifiably predict its derailment.


 October 29, 2007 at 11:14 am   Posted in: Health Law   Print This Post Print This Post

Responses (5)

  1. Patrick S. O'Donnell - October 29, 2007 at 11:46 am

    Frank,

    Thanks for the acknowledgment and link. In addition, the following titles should help readers unfamiliar with recent literature on some of the subects you raise here:

    Bolton, Derek and Jonathan Hill. Mind, Meaning, and Mental Disorder: The Nature of Causal Explanation in Psychology and Psychiatry (New York: Oxford University Press, 2003)

    Brody, Howard. Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry (Lanham, MD: Rowman & Littlefield, 2007)

    Buchanan, David R. An Ethic for Health Promotion: Rethinking the Sources of Human Well-Being (New York: Oxford University Press, 2000)

    Healy, David. The Creation of Psychopharmacology (Cambridge, MA: Harvard University Press, 2002)

    Ghaemi, S. Nassir. The Concepts of Psychiatry: A Pluralistic Approach to the Mind and Mental Illness (Baltimore, MD: Johns Hopkins University Press, 2003)

    Sadler, John Z., ed. Descriptions and Prescriptions: Values, Mental Disorders, and the DSMs (Baltimore, MD: Johns Hopkins University Press, 2002)

  2. Patrick S. O'Donnell - October 29, 2007 at 11:48 am

    Oops! Not in alphabetical order.

  3. Daniel Goldberg - October 29, 2007 at 12:52 pm

    Richard DeGrandpre’s work on behavioral pharmacologism is also worth reading on this point: The Cult of Pharmacology.

    Also, Frank, we’ve discussed this before, but I continue to think it is necessary to engage the epistemic problem of distinguishing enhancement from therapy.

  4. Frank - October 29, 2007 at 1:14 pm

    Patrick, thanks for that list!

    Daniel, I think my next post on this will be “How I Learned to Stop Worrying and Loathe the Therapy/Enhancement Distinction.” I’m beginning to think that there’s no way for theorists to convincingly draw a theoretical line between the two, and I’m beginning to doubt the utility of such a line. Aren’t the real questions here normative inquiries, such as “What is the good life” and “Does a particular intervention help or hinder our attaining it?”

    If the term “good life” seems to normatively loaded, I urge readers to substitute for it their own preferred formulations–”right conduct in light of natural reason,” “maximum utility,” “functionings,” “capabilities,” etc.

  5. Daniel Goldberg - October 29, 2007 at 1:34 pm

    Hey Frank,

    Oh, I completely agree there’s no such line, and given that I am a dedicated non-essentialist, I have no attachment to the necessity of drawing any such line.

    But if there’s no such line, I do think it means we need to think carefully about what “enhancement” actually means. In some sense, I think the term as a referent for a constellation of ethical problems is unhelpful and obscurantist, partly because it is unclear what is problematic about “enhancement” if in fact what constitutes enhancement might well be therapeutic for any given person or persons.

    So, I completely agree that the Platonic question is (as always) the important one. I just think scholars who work in these areas might generally find it more fruitful to engage what seems problematic about, e.g., medicalization of social problems without invoking the notion of enhancement (this is not intended as a not-so-veiled jab at you, BTW).

Leave a Reply

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word


  • « Previous post
  • Next post »

Authors

Daniel J. Solove
Kaimipono Wenger
Dave Hoffman
Nate Oman
Frank Pasquale
Deven Desai
Danielle Citron
Lawrence Cunningham
Sarah Waldeck
Jaya Ramji-Nogales
Solangel Maldonado
Gerard Magliocca

Guests

Adam Benforado
Mark Edwards
Michelle Harner
Kristin Johnson
Jeffrey Kahn
Alex Kreit
Viva Moffat
Adam Steinman










Previous Guests

Michael Abramowicz
Michelle Adams
Robert Ahdieh
Michelle Anderson
Laura Appleman
Ann Bartow
Francesca Bignami
Jeremy Blumenthal
Kathleen Boozang
Bruce Boyden
Donald Braman
Al Brophy
Neil H. Buchanan
Bill Burke-White
Scott Burris
Paul Butler
Naomi Cahn
Anupam Chander
Miriam Cherry
Jack Chin
Jennifer Collins
Thomas Crocker
Allison Danner
Brannon Denning
Deven Desai
Mike Dimino
Mark Edwards
David Fagundes
Christine Haight Farley
Kim Ferzan
Dan Filler
Michael Froomkin
Amanda Frost
Timothy Glynn
Rachel Godsil
Eric Goldman
David Gray
Craig Green
Tristin Green
Jeffrey Harrison
Erica Hashimoto
Carissa Hessick
Laura Heymann
Robert Hillman
Christine Hurt
Darian Ibrahim
John Ip
Kevin Johnson
Dan Kahan
Brian Kalt
Sam Kamin
Michael Kang
Chimène Keitner
Orin Kerr
Nancy Kim
Heidi Kitrosser
Adam Kolber
Russell Korobkin
Anita S. Krishnakumar
Susan Kuo
Greg Lastowka
Sarah Lawsky
Erik Lillquist
Jeff Lipshaw
Jonathan Lipson
Jacqueline Lipton
Joseph Liu
Michael Madison
Solangel Maldonado
Jason Mazzone
Linda McClain
William McGeveran
Salil Mehra
Carrie Menkel-Meadow
Max Minzner
Scott Moss
Eric Muller
Jaya Ramji-Nogales
Helen Norton
Elizabeth Nowicki
Paul Ohm
Michael O'Shea
David Opderback
Kristen Osenga
Rafael Pardo
Marcy Peek
Eduardo Peñalver
Robert Percival
David Post
Shruti Rana
Geoffrey Rapp
Neil Richards
Lori Ringhand
Alice Ristroph
Susan Scafidi
Paul Secunda
Jonathan Siegel
Jessica Silbey
Peter Smith
Charles Sullivan
Rick Swedloff
Steph Tai
Andrew Taslitz
Robert Tsai
Jenia Turner
Steve Vladeck
Spencer Weber Waller
Howard Wasserman
Melissa Waters
Frank Wu
Alfred Yen
Corey Yung
David Zaring
Timothy Zick
Michael Zimmer
Jonathan Zittrain

Ownership

Concurring Opinions is a
general-interest legal blog
operated by Concurring
Opinions LLC, a Pennsylvania
Limited Liability Corporation.

Blogroll

Above the Law
ACS Blog
Althouse
Balkinization
Becker-Posner Blog
BlackProf
BoingBoing
Chicago Law Faculty Blog
Conglomerate
CrimLaw
Crime & Federalism
CrimProf Blog
Crooked Timber
Discourse.net
Dorf on Law
Election Law
Emergent Chaos
The Faculty Lounge
Feminist Law Profs
43(B)log
Freakonomics Blog
Freedom to Tinker
Google Blogoscoped
How Appealing
Ideoblog
Info/Law
Instapundit.com
Juris Novus
Jurisdynamics
Law and Humanities Blog
Law and Letters
Law Librarian Blog
Legal Profession Blog
Legal Theory Blog
Legal Times Blog
Leiter Reports
Brian Leiter's Law School Reports
Lessig Blog
Madisonian Theory
Media Law Blog
Mirror of Justice
The Moderate Voice
National Security Advisors
Opinio Juris
Point of Law
PrawfsBlawg
ProfessorBainbridge.com
Property Prof Blog
Red Tape Chronicles
The Right Coast
Schneier on Security
SCOTUSBlog
Security Dilemmas
Sentencing Law and Policy
Simple Justice
Sivacracy.net
The Situationist
Susan Crawford
TalkLeft
Talking Points Memo
TaxProf Blog
Tech & Marketing Law
Truth on the Market
Volokh Conspiracy
WorkPlace Prof Blog
WSJ Law Blog
Wonkette
The Yin Blog


© Concurring Opinions

Powered by WordPress